Robust CGuard™ EPS year-over-year revenue growth of 31% Management to host investor conference call today, March 10, at 8:30am ET TEL AVIV, Israel, March 10, 2020 (GLOBE NEWSWIRE) — InspireMD, Inc. (NYSE American: NSPR), developer of the CGuard™ Embolic Prevention System (EPS) for the prevention of stroke caused by the treatment of […]
Other News
Catalyst Marketing Agency Wins CryoLife Business
Biomedical Company Hires Denver Agency for Strategic Guidance and Marketing Support DENVER–(BUSINESS WIRE)–Catalyst, a Denver marketing agency, today announced that they were selected by CryoLife, a biomedical company, for marketing services. The marketing services include design, content development and sales enablement tools creation. Headquartered in suburban Atlanta, Georgia, CryoLife is one of the […]
NanoSurface Bio Executes Exclusive License of Heart-on-Chip Technology Launched Into Space
SEATTLE–(BUSINESS WIRE)–NanoSurface Biomedical announced today that it has executed an exclusive IP license agreement related to innovative heart-on-chip technology developed by researchers at the University of Washington (UW). An experimental system built from the same heart-on-chip technology was launched into space on Friday, March 6, 2020 at 11:50 PM EST aboard […]
Heartseed and ITOCHU CHEMICAL FRONTIER Sign Capital Alliance Agreement to Explore iPSC and Cardiomyocyte Business Opportunities
TOKYO–(BUSINESS WIRE)–Heartseed Inc. (hereinafter Heartseed), a Tokyo-based biotechnology company developing iPSC-derived cardiomyocytes for the treatment of heart failure (HF), today announced it has entered into agreement with ITOCHU CHEMICAL FRONTIER Corporation (headquartered in Minato-ku, Tokyo; President & CEO Tsutomu Miyazaki, hereinafter ICF) to form a financial business partnership. In accordance […]
Impulse Dynamics Appoints Medical Director to Leadership Team
Ishu Rao, M.D., brings wealth of clinical expertise during time of rapid company growth MOUNT LAUREL, N.J.–(BUSINESS WIRE)–Impulse Dynamics, a company dedicated to improving the lives of people with heart failure and developer of the innovative CCM™ therapy delivered by the Optimizer® Smart System, today announced the appointment of Ishu Rao, […]
Quanterix Corporation Releases Operating Results for Fourth Quarter and Full Year 2019
46% Q4 revenue growth; 51% full year growth BILLERICA, Mass.–(BUSINESS WIRE)–Quanterix Corporation (NASDAQ: QTRX), a company digitizing biomarker analysis to advance the science of precision health, today announced financial results for the fourth quarter and 12 months ended December 31, 2019. “We’re pleased to close out another year of compelling […]
CARMAT Announces that It Has Achieved Record Individual Support of 2 Years With Its Bioprosthesis
PARIS–(BUSINESS WIRE)–Regulatory News: CARMAT (Paris:ALCAR) (FR0010907956, ALCAR), the designer and developer of the world’s most advanced total artificial heart, aiming to provide a therapeutic alternative for people suffering from end-stage biventricular heart failure, today announces that it has reached a major milestone by achieving record individual support of 2 years […]
Banook Group welcomes Turenne Santé as new investor, alongside the management
Funds obtained will enable the European leader in cardiac safety to continue its development in Europe, North America and Asia Nancy and Paris, France, March 10, 2020 – Banook Group, a clinical research organization (CRO) specialized in cardiac safety, centralized analyses of medical imagery and event adjudication, announces today that […]
TriGUARD 3™ Cerebral Embolic Protection Device Receives CE Mark for Use in Transcatheter Heart Procedures
TAMPA, FL March 10, 2020- Keystone Heart Ltd., a Venus Medtech Company, today announced European CE Mark for the TriGUARD 3™ Cerebral Embolic Protection (CEP) Device. The device is designed to minimize the risk of cerebral damage by deflecting embolic debris away from cerebral circulation during Transcatheter Aortic Valve Implantation […]
FierceMedTech Names BioVentrix as One of Its “Fierce 15” Companies of 2019
SAN RAMON, Calif.–(BUSINESS WIRE)–BioVentrix, Inc., developer of the first hybrid transcatheter device for left ventricular remodeling after a heart attack, today announced that it has been named by FierceMedTech as one of the “Fierce 15” for 2019, designating it as one of the most promising private medtech companies in the […]
Recent
Captive Radiology Secures Growth Investment to Accelerate Expansion and Enhance Patient Care Nationwide
Wolters Kluwer and Radiological Society of North America Establish 10-Year Agreement to Advance Global Access to Leading Radiology Research Journals
JenaValve Appoints Edward Sarnowski as Chief Technology Officer
Popular
- No commented posts yet